Biosimilars are a prescription for better health.
Biosimilars could lead to over $54 billion in savings over the next ten years, giving 1.2 million patients access to needed medicines.
Utilization of innovative and very costly medicines is expected to grow exponentially in the coming years. With biosimilars, these advanced treatments are poised to become available at a lower cost to millions of patients in the United States. A positive regulatory environment can increase biosimilar adoption.
Enter your email address below and receive the Biosimilars Bulletin – our monthly newsletter with the most recent information on biosimilars in the United States.
These resources provide answers around what biosimilars are, why they are important, how they can improve patient access, and how they can save the United States billions of dollars.